Summary
A 24-year-old patient had symptoms of lethargy, convulsions and hyperammonaemia during valproic acid therapy. Cessation of valproic acid treatment brought about an improvement both of the symptoms and of the hyperammonaemia. However, enzymatic analysis after the cessation of valproic acid therapy revealed a complete absence of carbamoylphosphate synthetase (CPS) activity in liver biopsy. A unique polypeptide band, corresponding to the control CPS protein in molecular weight (‘CPS-like’ protein), was found in normal amounts in the patient's liver on sodium dodecyl sulphate-polyacrylamide gel electrophoresis. This CPS-like protein seemed to be more labile than the control, because the polypeptide band became faint after freeze-thawing. Intravenous administration ofl-alanine resulted in a significant increase of serum urea and a transient increase of blood ammonia concentrations. These results strongly suggest that the patient has a labile CPS protein with no activityin vitro but some activityin vivo. We consider that valproic acid may have disrupted some metabolic adaptation by reducingN-acetylglutamate in the liver, which in combination with CPS deficiency induced severe hyperammonaemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alonso E, Girbés J, García-España A, Rubio V (1989) Changes in urea cycle-related metabolites in the mouse after combined administration of valproic acid and amino acid load.Arch Biochem Biophys 272: 267–273.
Batshaw ML, Brusilow SW (1982) Valproate-induced hyperammonemia.Ann Neurol 11: 319–321.
Bourrier P, Varache N, Alquier P et al (1988) Cerebral oedema with hyperammonemia in a case of valpromide intoxication.Presse Med. 17: 2063–2066.
Coude FX, Sweetman L, Nyhan WL (1979) Inhibition by propionyl-coenzyme A ofN-acetylglutamate synthetase in rat liver mitochondria.J Clin Invest 64: 1544–1551.
Coude FX, Rabier D, Cathelineau L, Grimber G, Parvy P, Kamoun PP (1981) A mechanism for valproate-induced hyperammonemia.Pediatr Res 15: 974–975.
Coude FX, Grimber G, Parvy P, Rabier D, Petit F (1983) Inhibition of ureagenesis by valproate in rat hepatocytes: Role ofN-acetylglutamate and acetyl-CoA.Biochem J 216: 233–236.
Gerber N, Dickinson RG, Harland RC et al (1979) Reye-like syndrome associated with valproic acid therapy.J Pediatr 95: 142–144.
Hjelm M, de Silva LVK, Seakins JWT, Oberholzer VG, Rolles CJ (1986) Evidence of inherited urea cycle defect in a case of fatal valproate toxicity.Br Med J 292: 23–24.
Kamoun PP, Rabier D (1987) Valproate-induced inhibition of urea synthesis.Lancet 1: 48.
Kay JD, Hilton-Jones D, Hyman N (1986) Valproate toxicity and ornithin carbamoyltransferase deficiency.Lancet 2: 1283–1284.
Kekomäki M, Visakorpi JD, Perheentupa J (1967) Familial protein intolerance with deficient transport of basic amino acid: an analysis of 10 patients.Acta Pediatr Scand 56: 617–630.
Kobayashi K, Saheki T, Imamura Y et al (1986) Messenger RNA coding for argininosuccinate synthetase in citrullinernia.Am J Hum Genet 38: 667–680.
McGregor AR, Crookall-Greening JO, Landon J, Smith DS (1978) Polarization fluoroimmunoassay of phenytoin.Clin Chim Acta 83: 161–166.
Perheentupa J, Visakorpi JK (1965) Protein intolerance with deficient transport of basic aminoacids.Lancet 2: 813–816.
Qureshi IA, Letarte J, Tuchweber B, Yousef I, Qureshi SR (1985) Hepatotoxicity of sodium valproate in ornithine transcarbamylase deficient mice.Toxicol Lett 25: 297–306.
Saheki T, Ueda A, Hosoya M et al (1981) Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia.Clin Chim Acta 109: 325–335.
Stewart PM, Walser M (1980) Failure of the normal ureagenic response to amino acids in organic acid-loaded rat.J Clin Invest 66: 484–492.
Suchy FJ, Balistreri WF, Buchino JJ et al (1979) Acute hepatic failure associated with the use of sodium valproate.N Engl J Med 300: 962–966.
Svensson G, Anfält T (1982) Rapid determination of ammonia in whole blood and plasma using flow injection analysis.Clin Chim Acta 119: 7–14.
Tripp JH, Hargreaves T, Anthony PP et al (1981) Sodium valproate and ornithine carbamyl transferase deficiency.Lancet 1: 1165–1166.
Ware S, Millward-Sadler GH (1980) Acute liver diseases associated with sodium valproate.Lancet 2: 1110–1113.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horiuchi, M., Imamura, Y., Nakamura, N. et al. Carbamoylphosphate synthetase deficiency in an adult: Deterioration due to administration of valproic acid. J Inherit Metab Dis 16, 39–45 (1993). https://doi.org/10.1007/BF00711313
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711313